Thymalin (20mg)

What is Thymalin?

Polypeptide complex restoring T-cell development capacity lost to aging.

Listed vial contents: 20mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.

What mechanisms are being studied?

Thymalin is a polypeptide complex extracted from thymus glands that normalizes T-helper/T-suppressor cell ratios and restores declining T-cell development capacity lost to thymic involution (age-related thymus shrinkage).

What are the research questions?

• Immune aging / thymic involution: Compensates for the natural decline in thymus function that begins in puberty and accelerates with age.
• Immunodeficiency: Restores T-cell populations in various immunocompromised states.
• Longevity: 6-8 year clinical studies demonstrated mortality reduction in elderly populations.

What does the published work describe?

Khavinson VKh, Morozov VG (Neuroendocrinol Lett 2003) — 6-8 year clinical studies showed significant mortality reduction in individuals over 60, with improved immune function and decreased cardiovascular mortality.

What are the limits of this evidence?

The research described concerns the cited experimental materials and models, not proof that this supplied vial is a treatment. Cell or animal findings do not establish human benefits. Clinical findings, where cited, apply to the tested formulation and population; they do not validate this research product for human use.

Study references

1. Khavinson VKh, Morozov VG. Neuroendocrinol Lett 2003

These are the catalog's existing bibliographic references. No new source verification is implied by this presentation.

How should I check lot documentation?

Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. Generated sample reports illustrate the reporting flow and are not evidence of testing, purity or accreditation.